Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
PBH's Cash to Debt is ranked lower than
100% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.57 vs. PBH: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
PBH' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.03 Max: N/A
Current: 0.03
Equity to Asset 0.27
PBH's Equity to Asset is ranked lower than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. PBH: 0.27 )
Ranked among companies with meaningful Equity to Asset only.
PBH' s Equity to Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.38 Max: 0.48
Current: 0.27
0.2
0.48
Interest Coverage 2.88
PBH's Interest Coverage is ranked lower than
85% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.22 vs. PBH: 2.88 )
Ranked among companies with meaningful Interest Coverage only.
PBH' s Interest Coverage Range Over the Past 10 Years
Min: 2.27  Med: 2.49 Max: 3.41
Current: 2.88
2.27
3.41
F-Score: 7
Z-Score: 1.69
M-Score: -2.65
WACC vs ROIC
8.91%
7.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 30.16
PBH's Operating margin (%) is ranked higher than
98% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.96 vs. PBH: 30.16 )
Ranked among companies with meaningful Operating margin (%) only.
PBH' s Operating margin (%) Range Over the Past 10 Years
Min: -55.89  Med: 28.14 Max: 31.57
Current: 30.16
-55.89
31.57
Net-margin (%) 12.53
PBH's Net-margin (%) is ranked higher than
86% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. PBH: 12.53 )
Ranked among companies with meaningful Net-margin (%) only.
PBH' s Net-margin (%) Range Over the Past 10 Years
Min: -61.61  Med: 10.48 Max: 12.16
Current: 12.53
-61.61
12.16
ROE (%) 16.28
PBH's ROE (%) is ranked higher than
67% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.13 vs. PBH: 16.28 )
Ranked among companies with meaningful ROE (%) only.
PBH' s ROE (%) Range Over the Past 10 Years
Min: -48.3  Med: 9.10 Max: 14.88
Current: 16.28
-48.3
14.88
ROA (%) 4.06
PBH's ROA (%) is ranked higher than
55% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.55 vs. PBH: 4.06 )
Ranked among companies with meaningful ROA (%) only.
PBH' s ROA (%) Range Over the Past 10 Years
Min: -20.19  Med: 3.32 Max: 4.11
Current: 4.06
-20.19
4.11
ROC (Joel Greenblatt) (%) 272.82
PBH's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.26 vs. PBH: 272.82 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PBH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -396.15  Med: 212.77 Max: 299.62
Current: 272.82
-396.15
299.62
Revenue Growth (3Y)(%) 16.00
PBH's Revenue Growth (3Y)(%) is ranked higher than
81% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. PBH: 16.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PBH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 14.35 Max: 84.1
Current: 16
0
84.1
EBITDA Growth (3Y)(%) 24.50
PBH's EBITDA Growth (3Y)(%) is ranked higher than
85% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. PBH: 24.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PBH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 25.80 Max: 59.1
Current: 24.5
0
59.1
EPS Growth (3Y)(%) 26.60
PBH's EPS Growth (3Y)(%) is ranked higher than
87% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. PBH: 26.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PBH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 25.80 Max: 263.6
Current: 26.6
0
263.6
» PBH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

PBH Guru Trades in Q1 2015

Joel Greenblatt 75,346 sh (+1019.89%)
Paul Tudor Jones 20,440 sh (+125.21%)
Wallace Weitz 160,000 sh (unchged)
Columbia Wanger Sold Out
Murray Stahl 94,395 sh (-2.91%)
Ken Fisher 1,388,125 sh (-4.05%)
» More
Q2 2015

PBH Guru Trades in Q2 2015

Jim Simons 17,300 sh (New)
Joel Greenblatt 269,476 sh (+257.65%)
Paul Tudor Jones 22,447 sh (+9.82%)
Wallace Weitz 160,000 sh (unchged)
Ken Fisher 1,382,350 sh (-0.42%)
Murray Stahl 91,666 sh (-2.89%)
» More
Q3 2015

PBH Guru Trades in Q3 2015

Jim Simons 156,400 sh (+804.05%)
Wallace Weitz Sold Out
Ken Fisher 1,377,407 sh (-0.36%)
Paul Tudor Jones 15,473 sh (-31.07%)
Joel Greenblatt 119,178 sh (-55.77%)
Murray Stahl 36,716 sh (-59.95%)
» More
Q4 2015

PBH Guru Trades in Q4 2015

Jim Simons 396,100 sh (+153.26%)
Ken Fisher 1,358,980 sh (-1.34%)
Murray Stahl 34,357 sh (-6.42%)
» More
» Details

Insider Trades

Latest Guru Trades with PBH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Prestige Brands Holdings Inc

Wallace Weitz Comments on Prestige Brands Holdings - Nov 06, 2015

Prestige Brands Holdings is engaged in the marketing, sales and distribution of brand name, over-the-counter healthcare and household cleaning products to mass merchandisers and drug stores in North America, Australia and other international markets. Prestige’s stock has appreciated due to an improved outlook for their consumer health products and the Company’s recent acquisition of the Monistat brand which appears on track to deliver additional future growth. We eliminated the position in the third quarter when the stock price reached our business value estimate.

From Wallace Weitz (Trades, Portfolio)'s Hickory Fund commentary for third quarter 2015.

Check out Wallace Weitz latest stock trades

Meridian Funds Comments on Prestige Brands - Sep 08, 2014

Prestige Brands (PBH) is the largest independent provider of over-the-counter products in North America. Examples of their brands include Chloraseptic, Dramamine, PediaCare and Efferdent, to name a few. We added to the position during the first quarter when the stock was one of the largest detractors, selling off for short-term reasons. The company experienced a decline in items stocked at one of the company’s largest customers, but we believe this is a temporary situation and our long- term thesis remains unchanged. This proved timely as the company demonstrated stabilized results during the second quarter and announced an acquisition, which drove the stock higher. Prestige Brands has an asset-light business model that focuses exclusively on the marketing and distribution of these brands, which results in a growing, scalable and high-return business model. We continue to hold the position.

From Meridian Funds (Trades, Portfolio)’ Meridian Growth Fund Second Quarter 2014 Commentary.

Check out Meridian Funds latest stock trades

Top Ranked Articles about Prestige Brands Holdings Inc

Wallace Weitz Comments on Prestige Brands Holdings Guru stock highlight
Prestige Brands Holdings is engaged in the marketing, sales and distribution of brand name, over-the-counter healthcare and household cleaning products to mass merchandisers and drug stores in North America, Australia and other international markets. Prestige’s stock has appreciated due to an improved outlook for their consumer health products and the Company’s recent acquisition of the Monistat brand which appears on track to deliver additional future growth. We eliminated the position in the third quarter when the stock price reached our business value estimate. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 21.60
PBH's P/E(ttm) is ranked lower than
58% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.52 vs. PBH: 21.60 )
Ranked among companies with meaningful P/E(ttm) only.
PBH' s P/E(ttm) Range Over the Past 10 Years
Min: 7.81  Med: 19.32 Max: 35.42
Current: 21.6
7.81
35.42
Forward P/E 25.00
PBH's Forward P/E is ranked lower than
94% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.19 vs. PBH: 25.00 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.60
PBH's PE(NRI) is ranked higher than
52% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.65 vs. PBH: 21.60 )
Ranked among companies with meaningful PE(NRI) only.
PBH' s PE(NRI) Range Over the Past 10 Years
Min: 7.93  Med: 19.30 Max: 35.78
Current: 21.6
7.93
35.78
P/B 3.49
PBH's P/B is ranked lower than
90% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.93 vs. PBH: 3.49 )
Ranked among companies with meaningful P/B only.
PBH' s P/B Range Over the Past 10 Years
Min: 0.54  Med: 1.54 Max: 4.17
Current: 3.49
0.54
4.17
P/S 2.95
PBH's P/S is ranked lower than
99.99% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.34 vs. PBH: 2.95 )
Ranked among companies with meaningful P/S only.
PBH' s P/S Range Over the Past 10 Years
Min: 0.67  Med: 1.77 Max: 3.35
Current: 2.95
0.67
3.35
PFCF 12.24
PBH's PFCF is ranked higher than
86% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.10 vs. PBH: 12.24 )
Ranked among companies with meaningful PFCF only.
PBH' s PFCF Range Over the Past 10 Years
Min: 3.11  Med: 10.87 Max: 110.68
Current: 12.24
3.11
110.68
POCF 11.94
PBH's POCF is ranked higher than
76% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.12 vs. PBH: 11.94 )
Ranked among companies with meaningful POCF only.
PBH' s POCF Range Over the Past 10 Years
Min: 3.08  Med: 9.56 Max: 105.15
Current: 11.94
3.08
105.15
EV-to-EBIT 14.25
PBH's EV-to-EBIT is ranked lower than
52% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.95 vs. PBH: 14.25 )
Ranked among companies with meaningful EV-to-EBIT only.
PBH' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.3  Med: 12.50 Max: 22.6
Current: 14.25
-4.3
22.6
EV-to-EBITDA 13.06
PBH's EV-to-EBITDA is ranked lower than
69% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.14 vs. PBH: 13.06 )
Ranked among companies with meaningful EV-to-EBITDA only.
PBH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4.6  Med: 11.20 Max: 20.8
Current: 13.06
-4.6
20.8
PEG 0.94
PBH's PEG is ranked higher than
78% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.47 vs. PBH: 0.94 )
Ranked among companies with meaningful PEG only.
PBH' s PEG Range Over the Past 10 Years
Min: 0.83  Med: 1.10 Max: 1.33
Current: 0.94
0.83
1.33
Shiller P/E 83.27
PBH's Shiller P/E is ranked lower than
92% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.83 vs. PBH: 83.27 )
Ranked among companies with meaningful Shiller P/E only.
PBH' s Shiller P/E Range Over the Past 10 Years
Min: 81.89  Med: 104.58 Max: 219.63
Current: 83.27
81.89
219.63
Current Ratio 2.63
PBH's Current Ratio is ranked higher than
82% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. PBH: 2.63 )
Ranked among companies with meaningful Current Ratio only.
PBH' s Current Ratio Range Over the Past 10 Years
Min: 1.7  Med: 2.20 Max: 3.98
Current: 2.63
1.7
3.98
Quick Ratio 1.70
PBH's Quick Ratio is ranked higher than
77% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.04 vs. PBH: 1.70 )
Ranked among companies with meaningful Quick Ratio only.
PBH' s Quick Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.38 Max: 3.05
Current: 1.7
1.08
3.05
Days Inventory 77.24
PBH's Days Inventory is ranked lower than
73% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.54 vs. PBH: 77.24 )
Ranked among companies with meaningful Days Inventory only.
PBH' s Days Inventory Range Over the Past 10 Years
Min: 69.11  Med: 75.29 Max: 87.68
Current: 77.24
69.11
87.68
Days Sales Outstanding 36.17
PBH's Days Sales Outstanding is ranked higher than
75% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.51 vs. PBH: 36.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
PBH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.2  Med: 43.53 Max: 49.84
Current: 36.17
38.2
49.84
Days Payable 28.92
PBH's Days Payable is ranked lower than
85% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.19 vs. PBH: 28.92 )
Ranked among companies with meaningful Days Payable only.
PBH' s Days Payable Range Over the Past 10 Years
Min: 33.5  Med: 47.36 Max: 67.85
Current: 28.92
33.5
67.85

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.78
PBH's Dividend Yield is ranked lower than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.96 vs. PBH: 0.78 )
Ranked among companies with meaningful Dividend Yield only.
PBH' s Dividend Yield Range Over the Past 10 Years
Min: 0.87  Med: 0.95 Max: 1.18
Current: 0.78
0.87
1.18
Yield on cost (5-Year) 0.78
PBH's Yield on cost (5-Year) is ranked lower than
96% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.95 vs. PBH: 0.78 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PBH' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.78  Med: 0.95 Max: 1.18
Current: 0.78
0.78
1.18
3-Year Average Share Buyback Ratio -1.20
PBH's 3-Year Average Share Buyback Ratio is ranked lower than
53% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.00 vs. PBH: -1.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PBH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -23.5  Med: -0.35 Max: 0
Current: -1.2
-23.5
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 3.75
PBH's Price/Projected FCF is ranked lower than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.29 vs. PBH: 3.75 )
Ranked among companies with meaningful Price/Projected FCF only.
PBH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.43  Med: 0.74 Max: 97.16
Current: 3.75
0.43
97.16
Price/Median PS Value 1.66
PBH's Price/Median PS Value is ranked lower than
100% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.15 vs. PBH: 1.66 )
Ranked among companies with meaningful Price/Median PS Value only.
PBH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.48  Med: 0.99 Max: 1.79
Current: 1.66
0.48
1.79
Price/Peter Lynch Fair Value 0.86
PBH's Price/Peter Lynch Fair Value is ranked higher than
75% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.19 vs. PBH: 0.86 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
PBH' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.88  Med: 1.16 Max: 2.27
Current: 0.86
0.88
2.27
Earnings Yield (Greenblatt) (%) 7.00
PBH's Earnings Yield (Greenblatt) (%) is ranked higher than
57% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.10 vs. PBH: 7.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PBH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.4  Med: 7.70 Max: 13.7
Current: 7
4.4
13.7
Forward Rate of Return (Yacktman) (%) 25.13
PBH's Forward Rate of Return (Yacktman) (%) is ranked higher than
83% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.68 vs. PBH: 25.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PBH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 4.6  Med: 11.20 Max: 29.2
Current: 25.13
4.6
29.2

More Statistics

Revenue(Mil) $859
EPS $ 2.21
Beta1.28
Short Percentage of Float5.11%
52-Week Range $37.72 - 54.25
Shares Outstanding(Mil)52.75

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:LRLCY, KMB, RBGPF, EL, UNLRY » details
Traded in other countries:PBV.Germany,
Prestige Brands Holdings Inc is incorporated in the State of Delaware in 1996. The Company sells healthcare, household cleaning and personal care products in North America. It conducts its operations through two main business segments Over-the-Counter Healthcare and Household Cleaning. The Company's portfolio of Over-the-Counter (OTC) Healthcare products includes 14 core brands, including five from the GSK Brands acquisitions. Its core OTC brands are Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Little Remedies and PediaCare pediatric healthcare products, The Doctor's brand of oral care products, Efferdent and Effergrip denture products, Luden's drops, Dramamine motion sickness products, BC and Goody's analgesic powders, Beano gas prevention, Gaviscon antacids, and Debrox ear drops. Its other significant brands include Dermoplast first-aid products, Murine eye and ear care products, NasalCrom allergy prevention relief product, New-Skin liquid bandage, Wartner wart removers, Fiber Choice fiber laxative supplements, and Ecotrin aspirin. The Company's portfolio of household cleaning brands includes the Comet, Chore Boy and Spic and Span brands. Comet was originally introduced in 1956 and is recognized household cleaning brands. Chore Boy scrubbing pads and sponges were initially launched in the 1920's. Chore Boy products are currently sold in food and drugs stores, mass merchandisers, and in hardware and convenience stores. Competitors in the OTC Healthcare category include Johnson & Johnson; McNeil-PPC Tylenol(r) and Novartis Consumer Healthcare, each of which competes with its PediaCare and Little Remedies brands; The Procter & Gamble Company, maker of Vicks(r), and Reckitt Benckiser, maker of Cepacol(r), each of which competes with its Chloraseptic brand; Kraft Foods, maker of Halls(r), which competes with ourLuden's brand; The Procter & Gamble Company, maker of Fixodent(r), and GlaxoSmithKline, maker of Polident(r), each of which competes with its Efferdent brand; and Insight Pharmaceuticals, Inc., maker of Bonine(r), which competes with its Dramamine brand. Sunstar America, Inc., maker of the GUM(r) line of oral care products, as well as DenTek(r) Oral Care, Inc., which markets a dental protector for nighttime teeth grinding and interdental toothpicks, competes with its The Doctor's oral care brand. Competitors in the Household Cleaning category include: Henkel AG & Co., maker of Ajax(r) Cleanser, and The Clorox Company, maker of Tilex(r), each of which competes with its Comet brand. Additionally, Clorox's Pine Sol(r) and The Procter & Gamble Company's Mr. Clean(r) compete with its Spic and Span brand, while 3M Company, maker of Scotch-Brite(r),O-Cel-O(r) and Dobie(r) brands, and Clorox's SOS(r), compete with its Chore Boy brand. The Company is subject to a variety of other regulations in various foreign markets, including regulations pertaining to import/export regulations and antitrust iss
» More Articles for PBH

Headlines

Articles On GuruFocus.com
Wallace Weitz Comments on Prestige Brands Holdings Nov 06 2015 
Earnings Upward Reaction: Prestige Brands Holdings (PBH), Proto Labs (PRLB) Feb 05 2015 
Meridian Funds Comments on Prestige Brands Sep 08 2014 
Meridian Growth Fund Second Quarter 2014 Commentary Sep 08 2014 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
Private Capital Management Sells Update Nov 27 2013 
Gold Guru John Paulson Drops Gold ABX in First Quarter Sells May 18 2013 
Weekly CEO Sells Highlight: Smiths News, Prestige Brands Holdings, Proto Labs, Imax Corp Nov 26 2012 
Why I'd Never Pay More Than Book Value for Nokia (NOK) Apr 12 2012 
Prestige Brands Holdings Inc. Reports Operating Results (10-Q) Feb 09 2011 

More From Other Websites
Prestige Brands Holdings, Inc. Earnings Analysis: Q3, 2016 By the Numbers Feb 11 2016
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 09 2016
PRESTIGE BRANDS HOLDINGS, INC. Financials Feb 09 2016
Prestige Brands Holdings, Inc. Completes Acquisition of DenTek Holdings, Inc. Feb 08 2016
Prestige Brands Holdings, Inc.: Strong price momentum but will it sustain? Feb 05 2016
Coverage initiated on Prestige Brands by Piper Jaffray Feb 05 2016
Edited Transcript of PBH earnings conference call or presentation 4-Feb-16 1:30pm GMT Feb 04 2016
Stocks End Choppy Day Slightly Up; Kohl’s, LinkedIn Crumble Feb 04 2016
Prestige Brands Holdings Is Up More Than 11% Feb 04 2016
Prestige Brands Holdings Inc Earnings Call scheduled for 8:30 am ET today Feb 04 2016
Q3 2016 Prestige Brands Holdings Inc Earnings Release - Before Market Open Feb 04 2016
Prestige Brands tops Street 3Q forecasts Feb 04 2016
Prestige Brands tops Street 3Q forecasts Feb 04 2016
PRESTIGE BRANDS HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 04 2016
Prestige Brands Holdings, Inc. Reports Fiscal 2016 Third Quarter and Year-to-Date Results Feb 04 2016
Prestige Brands Holdings, Inc. to Release Fiscal 2016 Third Quarter Earnings on February 4th Jan 08 2016
Prestige Brands Holdings, Inc. to Release Fiscal 2016 Third Quarter Earnings on February 4th Jan 08 2016
Prestige Brands Holdings, Inc. – Value Analysis (NYSE:PBH) : January 5, 2016 Jan 05 2016
Prestige Brands Holdings, Inc. breached its 50 day moving average in a Bearish Manner : January 5,... Jan 05 2016
3 Small-Cap, Best-in-Breed Health Care Stocks With Momentum for 2016 Dec 22 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK